AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

94,300

Employees94,300

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1913

Founded1913

Employees

94,300

Employees94,300

AZN Key Statistics

Market cap

297.23B

Market cap297.23B

Price-Earnings ratio

31.35

Price-Earnings ratio31.35

Dividend yield

1.61%

Dividend yield1.61%

Average volume

3.71M

Average volume3.71M

High today

$95.94

High today$95.94

Low today

$94.69

Low today$94.69

Open price

$95.21

Open price$95.21

Volume

3.12M

Volume3.12M

52 Week high

$96.51

52 Week high$96.51

52 Week low

$61.24

52 Week low$61.24

AZN News

TipRanks 38m

AstraZeneca Clears an Early Safety Hurdle With AZD0780–Metformin Interaction Study

AstraZeneca (AZN) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium AstraZeneca Explores How New Drug AZD0780 Interacts With...

TipRanks 2d

AstraZeneca: Broad Late-Stage Pipeline, Emerging Obesity Franchise, and Autoimmune CAR-T Platform Support Upside and Buy Rating

Analyst Sachin Jain of Bank of America Securities reiterated a Buy rating on AstraZeneca, retaining the price target of p16,500.00. Claim 70% Off TipRanks Premi...

Benzinga 3d

AstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial

On Tuesday, AstraZeneca Plc (NASDAQ:AZN) released complete results from the Phase 3 TULIP-SC trial of a subcutaneous (SC) administration of anifrolumab versus p...

Analyst ratings

81%

of 32 ratings

Buy

81.3%

Hold

9.4%

Sell

9.4%

More AZN News

TipRanks 4d

AstraZeneca removed from European Conviction List at Goldman Sachs

Goldman Sachs analysts removed AstraZeneca (AZN) from the firm’s European Conviction List as part of its monthly update. Claim 70% Off TipRanks This Holiday Se...